Skip to main content
SpringerLink
Log in

Narcolepsy and Developmental Disability

  • Chapter
Narcolepsy

  • 1618 Accesses

Abstract

In New York State, the Office for People with Developmental Disabilities (OPWDD) coordinates and provides services for people with developmental disabilities provided they meet eligibility requirements. For narcolepsy, deficits in adaptive functioning are the primary requirement rather than deficits in cognitive functioning. Here we provide a summary of the requirements and provide examples of persons with narcolepsy that have and have not met the requirements.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5. 5th ed. Washington, DC: American Psychiatric Association; 2013.

    Google Scholar 

  2. American Educational Research Association, American Psychological Association, and National Council on Measurement in Education. Standards for educational and psychological testing. Washington, DC; 1999.

    Google Scholar 

  3. Nishino S, Ripley B, Overeem S, Lammers GJ, Mignot E. Hypocretin (Orexin) deficiency in human narcolepsy. Lancet. 2000;355(9197):39–40.

    Article  PubMed  CAS  Google Scholar 

  4. Leschziner G. Narcolepsy: a clinical review. Pract Neurol. 2014;14(5):323–33.

    Article  PubMed  Google Scholar 

  5. Mignot E, Hayduk R, Black J, Grumet FC, Guilleminault C. HLA DQB1*0602 is associated with cataplexy in 509 narcoleptic patients. Sleep. 1997;20(11):1012–20.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute for Basic Research in Developmental Disabilities, Staten Island, NY, USA

    William Ted Brown MD, PhD

  2. Narcolepsy Institute, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA

    Meeta Goswami BDS, MPH, PhD

Authors
  1. William Ted Brown MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Meeta Goswami BDS, MPH, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to William Ted Brown MD, PhD .

Editor information

Editors and Affiliations

  1. Montefiore Medical Center Narcolepsy Institute, Bronx, New York, USA

    Meeta Goswami

  2. Montefiore Hospital Sleep-Wake Disorders Center, Bronx, New York, USA

    Michael J. Thorpy

  3. Somnogen Canada Inc, President and Chief Executive Officer, Toronto, Ontario, Canada

    S.R. Pandi-Perumal

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Brown, W.T., Goswami, M. (2016). Narcolepsy and Developmental Disability. In: Goswami, M., Thorpy, M., Pandi-Perumal, S. (eds) Narcolepsy. Springer, Cham. https://doi.org/10.1007/978-3-319-23739-8_28

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-23739-8_28

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-23738-1

  • Online ISBN: 978-3-319-23739-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation